Table 1.
Demographics and IVF/ICSI treatment characteristics of the women with tubal infertility and PCOS.
| PCOS (n = 160) | Tubal infertility (n = 1073) | t | χ2 | p-value | |
|---|---|---|---|---|---|
| Age (y) | 36.66 ± 2.10 | 37.74 ± 2.55 | -5.123 | <0.001* | |
| Infertility duration (y) | 5.36 ± 3.88 | 4.30 ± 3.88 | 3.215 | 0.001* | |
| BMI (kg/m2) | 25.43 ± 3.37 | 23.80 ± 2.98 | 6.349 | <0.001* | |
| Basal FSH (IU/L) | 6.47 ± 1.76 | 7.27 ± 2.26 | -4.316 | <0.001* | |
| Basal LH (IU/L) | 7.56 ± 5.43 | 4.69 ± 2.54 | 11.001 | <0.001* | |
| LH/FSH | 1.23 ± 1.01 | 0.67 ± 0.39 | 12.745 | <0.001* | |
| Basal T (nmol/l) | 0.89 ± 00.44 | 0.65 ± 0.38 | 7.296 | <0.001* | |
| AFC | 23.56 ± 4.98 | 13.40 ± 4.99 | 24.029 | <0.001* | |
| AMH (pmol/l) | 45.07 ± 24.02 | 19.22 ± 11.13 | 20.639 | <0.001* | |
| Insulin resistance (%)1 1 | 79.61% (82/102) | 78.71% (159/202) | 0.033 | 0.855 | |
| Starting Gn (IU) | 189.45 ± 57.88 | 252.04 ± 99.70 | -7.747 | <0.001* | |
| Gn duration (day) | 13.31 ± 2.70 | 13.00 ± 2.19 | 1.656 | 0.098 | |
| rLH supplementation (Y/N) (%) | 76.88% (123/160) | 52.47% (563/1073) | 33.600 | <0.001* | |
| Number of oocytes retrieved | 15.44 ± 6.71 | 11.35 ± 5.92 | 8.000 | <0.001* | |
| Number of 2PN | 10.31 ± 5.76 | 7.09 ± 4.34 | 8.339 | <0.001* |
Values are expressed as percentage (%) or mean and standard deviation (SD). P-value < 0.05 (asterisk) was considered statistically significant. (IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; PCOS, Polycystic ovary syndrome; BMI, body mass index; LH, luteinizing hormone; FSH, follicle-stimulating hormone; T, testosterone; Gn, gonadotropin; rLH, recombinant luteinizing hormone).
1There were 58 patients in the PCSO group who had no insulin release test, and 871 patients in the tubal infertility group who had no insulin release test.
The result of the P value is shown in italics.